Parkside Financial Bank & Trust’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28K Sell
90
-404
-82% -$12.7K ﹤0.01% 2024
2026
Q1
$13.8K Sell
494
-993
-67% -$32.6K ﹤0.01% 1459
2025
Q4
$55.6K Buy
1,487
+40
+3% +$1.31K ﹤0.01% 920
2025
Q3
$39.9K Buy
1,447
+290
+25% +$9.99K ﹤0.01% 1016
2025
Q2
$36.6K Buy
1,157
+1,130
+4,185% +$36.4K ﹤0.01% 1010
2025
Q1
$897 Buy
27
+15
+125% +$538 ﹤0.01% 2146
2024
Q4
$413 Hold
12
﹤0.01% 1911
2024
Q3
$480 Hold
12
﹤0.01% 1838
2024
Q2
$363 Hold
12
﹤0.01% 1839
2024
Q1
$403 Hold
12
﹤0.01% 1796
2023
Q4
$388 Buy
+12
New +$335 ﹤0.01% 1801
2023
Q3
Sell
-35
Closed -$1.23K 2075
2023
Q2
$1.23K Buy
35
+29
+483% +$1K ﹤0.01% 1801
2023
Q1
$196 Sell
6
-76
-93% -$3.46K ﹤0.01% 1956
2022
Q4
$4.52K Hold
82
﹤0.01% 1362
2022
Q3
$4K Buy
82
+40
+95% +$1.95K ﹤0.01% 1305
2022
Q2
$2K Buy
42
+10
+31% +$450 ﹤0.01% 1572
2022
Q1
$2K Sell
32
-44
-58% -$1.79K ﹤0.01% 1604
2021
Q4
$3K Buy
+76
New +$3.03K ﹤0.01% 1495

Other funds holding HRMY

Parkside Financial Bank & Trust's HRMY Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Harmony Biosciences (HRMY) stake by 82% in Q2 2026, selling an estimated $12.7K and leaving 90 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2024.

Parkside Financial Bank & Trust first reported a position in HRMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $55.6K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Parkside Financial Bank & Trust held 90 shares of Harmony Biosciences worth $3.28K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 404 Harmony Biosciences shares in Q2 2026, an estimated $12.7K.
  • Harmony Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2024 holding.
  • Parkside Financial Bank & Trust first reported a position in Harmony Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Parkside Financial Bank & Trust's Harmony Biosciences position peaked at $55.6K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.